Harvest Fund Management Co. Ltd Has $87,000 Stock Position in The Clorox Company (NYSE:CLX)

Harvest Fund Management Co. Ltd boosted its position in shares of The Clorox Company (NYSE:CLX) by 4,257.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 610 shares of the company’s stock after purchasing an additional 596 shares during the period. Harvest Fund Management Co. Ltd’s holdings in Clorox were worth $87,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. First National Bank of Mount Dora Trust Investment Services lifted its position in shares of Clorox by 3.2% in the fourth quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock worth $322,000 after buying an additional 71 shares during the last quarter. Modera Wealth Management LLC lifted its position in shares of Clorox by 1.4% during the 3rd quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock worth $672,000 after purchasing an additional 71 shares during the last quarter. Czech National Bank lifted its position in shares of Clorox by 0.3% during the 4th quarter. Czech National Bank now owns 21,718 shares of the company’s stock worth $3,097,000 after purchasing an additional 71 shares during the last quarter. Global Retirement Partners LLC lifted its position in shares of Clorox by 7.2% during the 4th quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock worth $156,000 after purchasing an additional 73 shares during the last quarter. Finally, West Branch Capital LLC lifted its position in shares of Clorox by 9.3% during the 4th quarter. West Branch Capital LLC now owns 903 shares of the company’s stock worth $129,000 after purchasing an additional 77 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 0.2 %

Shares of CLX opened at $147.51 on Friday. The company has a market capitalization of $18.31 billion, a P/E ratio of 234.15, a PEG ratio of 2.34 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The Clorox Company has a one year low of $114.68 and a one year high of $178.21. The business’s 50 day simple moving average is $149.48 and its 200-day simple moving average is $142.31.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, February 1st. The company reported $2.16 EPS for the quarter, topping the consensus estimate of $1.08 by $1.08. The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. Clorox’s revenue was up 16.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.98 EPS. As a group, sell-side analysts predict that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 annualized dividend and a dividend yield of 3.25%. The ex-dividend date is Tuesday, April 23rd. Clorox’s payout ratio is currently 761.92%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CLX shares. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective for the company in a research report on Tuesday, March 26th. UBS Group boosted their price target on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, February 2nd. DA Davidson restated a “neutral” rating and set a $162.00 price target on shares of Clorox in a research note on Wednesday, April 17th. Barclays lowered their price target on Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research note on Wednesday, April 10th. Finally, The Goldman Sachs Group started coverage on Clorox in a research note on Friday, March 1st. They set a “sell” rating and a $140.00 price target on the stock. Four investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.